Vyne Therapeutics Inc.
VYNE
Revenue
69.00k
▼-133.00k▼-65.84%
3 Months ChangeAssets
30.16M
▼-14.56M▼-32.56%
6 Months ChangeLiabilities
2.40M
▼-3.44M▼-58.96%
6 Months ChangeFree Cash Flow
-12.55M
▲39.70M▲75.98%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-01-30
Form 8-K
ID: 0001104659-26-008642
2025-12-17
Form 8-K
ID: 0001104659-25-121828
2025-12-12
Form 8-K
ID: 0001104659-25-120637
2025-11-06
Form 10-Q
ID: 0001566044-25-000010
2025-11-06
Form 8-K
ID: 0001566044-25-000007
2025-09-12
Form 8-K
ID: 0001104659-25-089531
2025-08-14
Form 10-Q
ID: 0001628280-25-040366
2025-08-14
Form 8-K
ID: 0001104659-25-078135
2025-07-30
Form 8-K
ID: 0001104659-25-071953
2025-05-08
Form 10-Q
ID: 0001628280-25-023740